Loading…
Improving outcome in schizophrenia: the case for early intervention
The evidence implies that intervention early in the development of psychosis may lead to complete, or almost complete, recovery in a much larger proportion of patients than is currently the case. The beneficial effects of early intervention are supported by the suggestions that untreated psychosis m...
Saved in:
Published in: | Canadian Medical Association journal (CMAJ) 1999-03, Vol.160 (6), p.843-846 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 846 |
container_issue | 6 |
container_start_page | 843 |
container_title | Canadian Medical Association journal (CMAJ) |
container_volume | 160 |
creator | Malla, A K Norman, R M Voruganti, L P |
description | The evidence implies that intervention early in the development of psychosis may lead to complete, or almost complete, recovery in a much larger proportion of patients than is currently the case. The beneficial effects of early intervention are supported by the suggestions that untreated psychosis may have a noxious effect on brain functioning,13 that patients experiencing their first episode of schizophrenic psychosis are much more responsive to antipsychotic medication than during subsequent episodes58 and that relatively low doses of antipsychotic drugs are needed at this stage.59 In addition, patients' social supports and insight, 2 important determinants of outcome,60,61 are likely to still exist during the early stages. Outcome studies in schizophrenia show that the greatest decline in functioning occurs in the first few years of the illness.' A longer period of illness is associated with increasing negative symptoms and cognitive and behavioural deficits.62 Medical and psychosocial interventions may be more effective when newer antipsychotics are used at a relatively early stage. The combination of better tolerance and greater brain plasticity associated with the new drugs could render the patient more amenable to psychosocial interventions. Therefore, evaluating the potential benefits of early intervention for psychosis must be a high priority. Systemic factors may also delay the initiation of treatment. These largely reflect the availability of appropriate professional services. Patients in whom a psychotic disorder is eventually diagnosed have frequently visited a physician for related problems, but the underlying illness remains undiagnosed.70 As a result, most patients with schizophrenia are subject to the deleterious effects of delay in the initiation of treatment. Strategies for reducing the duration of untreated psychosis that could be evaluated include teaching better methods of case detection at the primary care level, increasing awareness of psychosis among the public and targeting high-risk populations for early case detection and intervention. It has been proposed that "indicated prevention" efforts71 be directed toward people who are at high risk and who show minimal, yet detectable, signs and symptoms, but who do not meet the criteria for schizophrenia.72 The definition of "caseness" - the point at which a patient can be regarded as suffering from psychosis and in need of treatment--would have to be adjusted, so that treatment for psy |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1230170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69668145</sourcerecordid><originalsourceid>FETCH-LOGICAL-p289t-62628d49446f3aec98a31219831acbbc091fe0aa7f139f60c4f5f42bfff4c7f13</originalsourceid><addsrcrecordid>eNpdkE9LAzEQxYMotla_giwevC3k32YTD4IUq4WCFz2HbJp0U3aTNdkt1E_vqlXUuQzMe_zmzRyBKaKc55hgcQymkGOYE0HZBJyltIVjEVyeggmCiAtK6BTMl20Xw875TRaGXofWZM5nSdfuLXR1NN6pm6yvTaZVMpkNMTMqNvvR1Ju4M753wZ-DE6uaZC4OfQZeFvfP88d89fSwnN-t8g5z0ecMM8zXVFDKLFFGC64IwkhwgpSuKg0FsgYqVVpEhGVQU1tYiitrLdUfwxm4_eJ2Q9WatR63R9XILrpWxb0Mysm_ine13ISdRJhAVMIRcH0AxPA6mNTL1iVtmkZ5E4YkmWCMI1qMxqt_xm0Yoh-PkxjSUhTFJ-3yd5yfHN_PJe9ojHgi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204795570</pqid></control><display><type>article</type><title>Improving outcome in schizophrenia: the case for early intervention</title><source>PubMed Central</source><creator>Malla, A K ; Norman, R M ; Voruganti, L P</creator><creatorcontrib>Malla, A K ; Norman, R M ; Voruganti, L P</creatorcontrib><description>The evidence implies that intervention early in the development of psychosis may lead to complete, or almost complete, recovery in a much larger proportion of patients than is currently the case. The beneficial effects of early intervention are supported by the suggestions that untreated psychosis may have a noxious effect on brain functioning,13 that patients experiencing their first episode of schizophrenic psychosis are much more responsive to antipsychotic medication than during subsequent episodes58 and that relatively low doses of antipsychotic drugs are needed at this stage.59 In addition, patients' social supports and insight, 2 important determinants of outcome,60,61 are likely to still exist during the early stages. Outcome studies in schizophrenia show that the greatest decline in functioning occurs in the first few years of the illness.' A longer period of illness is associated with increasing negative symptoms and cognitive and behavioural deficits.62 Medical and psychosocial interventions may be more effective when newer antipsychotics are used at a relatively early stage. The combination of better tolerance and greater brain plasticity associated with the new drugs could render the patient more amenable to psychosocial interventions. Therefore, evaluating the potential benefits of early intervention for psychosis must be a high priority. Systemic factors may also delay the initiation of treatment. These largely reflect the availability of appropriate professional services. Patients in whom a psychotic disorder is eventually diagnosed have frequently visited a physician for related problems, but the underlying illness remains undiagnosed.70 As a result, most patients with schizophrenia are subject to the deleterious effects of delay in the initiation of treatment. Strategies for reducing the duration of untreated psychosis that could be evaluated include teaching better methods of case detection at the primary care level, increasing awareness of psychosis among the public and targeting high-risk populations for early case detection and intervention. It has been proposed that "indicated prevention" efforts71 be directed toward people who are at high risk and who show minimal, yet detectable, signs and symptoms, but who do not meet the criteria for schizophrenia.72 The definition of "caseness" - the point at which a patient can be regarded as suffering from psychosis and in need of treatment--would have to be adjusted, so that treatment for psychosis could be initiated even in the absence of a definitive diagnosis of schizophrenia. 50. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzen LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145-51. 51. Strauss JS, Carpenter AAT Jr. Prediction of outcome in schizophrenia: III. Five-year outcome and its predictors. Arch Gen Prychiatry 1977;34:159-63. 52. Kendler KS, Gruenberg .MU, Tsuang MT. Outcome of schizophrenic subtypes defined by four diagnostic systems. Arch Gen Psychiat 1984;41:149-54. 53. Peterson DB, Olson GW. First admitted schizophrenics in drug era. Arch Gen Psychiatry 1964;11:137-44.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>PMID: 10189434</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Canada: CMA Impact, Inc</publisher><subject>Antipsychotic Agents - therapeutic use ; Disease Progression ; Humans ; Mental disorders ; Nursing ; Predictive Value of Tests ; Prognosis ; Review ; Risk Factors ; Schizophrenia ; Schizophrenia - diagnosis ; Schizophrenia - drug therapy ; Therapy ; Time Factors ; Treatment Outcome</subject><ispartof>Canadian Medical Association journal (CMAJ), 1999-03, Vol.160 (6), p.843-846</ispartof><rights>Copyright Canadian Medical Association Mar 23, 1999</rights><rights>1999 Canadian Medical Association 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1230170/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1230170/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10189434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malla, A K</creatorcontrib><creatorcontrib>Norman, R M</creatorcontrib><creatorcontrib>Voruganti, L P</creatorcontrib><title>Improving outcome in schizophrenia: the case for early intervention</title><title>Canadian Medical Association journal (CMAJ)</title><addtitle>CMAJ</addtitle><description>The evidence implies that intervention early in the development of psychosis may lead to complete, or almost complete, recovery in a much larger proportion of patients than is currently the case. The beneficial effects of early intervention are supported by the suggestions that untreated psychosis may have a noxious effect on brain functioning,13 that patients experiencing their first episode of schizophrenic psychosis are much more responsive to antipsychotic medication than during subsequent episodes58 and that relatively low doses of antipsychotic drugs are needed at this stage.59 In addition, patients' social supports and insight, 2 important determinants of outcome,60,61 are likely to still exist during the early stages. Outcome studies in schizophrenia show that the greatest decline in functioning occurs in the first few years of the illness.' A longer period of illness is associated with increasing negative symptoms and cognitive and behavioural deficits.62 Medical and psychosocial interventions may be more effective when newer antipsychotics are used at a relatively early stage. The combination of better tolerance and greater brain plasticity associated with the new drugs could render the patient more amenable to psychosocial interventions. Therefore, evaluating the potential benefits of early intervention for psychosis must be a high priority. Systemic factors may also delay the initiation of treatment. These largely reflect the availability of appropriate professional services. Patients in whom a psychotic disorder is eventually diagnosed have frequently visited a physician for related problems, but the underlying illness remains undiagnosed.70 As a result, most patients with schizophrenia are subject to the deleterious effects of delay in the initiation of treatment. Strategies for reducing the duration of untreated psychosis that could be evaluated include teaching better methods of case detection at the primary care level, increasing awareness of psychosis among the public and targeting high-risk populations for early case detection and intervention. It has been proposed that "indicated prevention" efforts71 be directed toward people who are at high risk and who show minimal, yet detectable, signs and symptoms, but who do not meet the criteria for schizophrenia.72 The definition of "caseness" - the point at which a patient can be regarded as suffering from psychosis and in need of treatment--would have to be adjusted, so that treatment for psychosis could be initiated even in the absence of a definitive diagnosis of schizophrenia. 50. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzen LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145-51. 51. Strauss JS, Carpenter AAT Jr. Prediction of outcome in schizophrenia: III. Five-year outcome and its predictors. Arch Gen Prychiatry 1977;34:159-63. 52. Kendler KS, Gruenberg .MU, Tsuang MT. Outcome of schizophrenic subtypes defined by four diagnostic systems. Arch Gen Psychiat 1984;41:149-54. 53. Peterson DB, Olson GW. First admitted schizophrenics in drug era. Arch Gen Psychiatry 1964;11:137-44.</description><subject>Antipsychotic Agents - therapeutic use</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Mental disorders</subject><subject>Nursing</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Schizophrenia</subject><subject>Schizophrenia - diagnosis</subject><subject>Schizophrenia - drug therapy</subject><subject>Therapy</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpdkE9LAzEQxYMotla_giwevC3k32YTD4IUq4WCFz2HbJp0U3aTNdkt1E_vqlXUuQzMe_zmzRyBKaKc55hgcQymkGOYE0HZBJyltIVjEVyeggmCiAtK6BTMl20Xw875TRaGXofWZM5nSdfuLXR1NN6pm6yvTaZVMpkNMTMqNvvR1Ju4M753wZ-DE6uaZC4OfQZeFvfP88d89fSwnN-t8g5z0ecMM8zXVFDKLFFGC64IwkhwgpSuKg0FsgYqVVpEhGVQU1tYiitrLdUfwxm4_eJ2Q9WatR63R9XILrpWxb0Mysm_ine13ISdRJhAVMIRcH0AxPA6mNTL1iVtmkZ5E4YkmWCMI1qMxqt_xm0Yoh-PkxjSUhTFJ-3yd5yfHN_PJe9ojHgi</recordid><startdate>19990323</startdate><enddate>19990323</enddate><creator>Malla, A K</creator><creator>Norman, R M</creator><creator>Voruganti, L P</creator><general>CMA Impact, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990323</creationdate><title>Improving outcome in schizophrenia: the case for early intervention</title><author>Malla, A K ; Norman, R M ; Voruganti, L P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p289t-62628d49446f3aec98a31219831acbbc091fe0aa7f139f60c4f5f42bfff4c7f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Antipsychotic Agents - therapeutic use</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Mental disorders</topic><topic>Nursing</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Schizophrenia</topic><topic>Schizophrenia - diagnosis</topic><topic>Schizophrenia - drug therapy</topic><topic>Therapy</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malla, A K</creatorcontrib><creatorcontrib>Norman, R M</creatorcontrib><creatorcontrib>Voruganti, L P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>ProQuest Science Journals</collection><collection>CBCA Reference & Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malla, A K</au><au>Norman, R M</au><au>Voruganti, L P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improving outcome in schizophrenia: the case for early intervention</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><addtitle>CMAJ</addtitle><date>1999-03-23</date><risdate>1999</risdate><volume>160</volume><issue>6</issue><spage>843</spage><epage>846</epage><pages>843-846</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><abstract>The evidence implies that intervention early in the development of psychosis may lead to complete, or almost complete, recovery in a much larger proportion of patients than is currently the case. The beneficial effects of early intervention are supported by the suggestions that untreated psychosis may have a noxious effect on brain functioning,13 that patients experiencing their first episode of schizophrenic psychosis are much more responsive to antipsychotic medication than during subsequent episodes58 and that relatively low doses of antipsychotic drugs are needed at this stage.59 In addition, patients' social supports and insight, 2 important determinants of outcome,60,61 are likely to still exist during the early stages. Outcome studies in schizophrenia show that the greatest decline in functioning occurs in the first few years of the illness.' A longer period of illness is associated with increasing negative symptoms and cognitive and behavioural deficits.62 Medical and psychosocial interventions may be more effective when newer antipsychotics are used at a relatively early stage. The combination of better tolerance and greater brain plasticity associated with the new drugs could render the patient more amenable to psychosocial interventions. Therefore, evaluating the potential benefits of early intervention for psychosis must be a high priority. Systemic factors may also delay the initiation of treatment. These largely reflect the availability of appropriate professional services. Patients in whom a psychotic disorder is eventually diagnosed have frequently visited a physician for related problems, but the underlying illness remains undiagnosed.70 As a result, most patients with schizophrenia are subject to the deleterious effects of delay in the initiation of treatment. Strategies for reducing the duration of untreated psychosis that could be evaluated include teaching better methods of case detection at the primary care level, increasing awareness of psychosis among the public and targeting high-risk populations for early case detection and intervention. It has been proposed that "indicated prevention" efforts71 be directed toward people who are at high risk and who show minimal, yet detectable, signs and symptoms, but who do not meet the criteria for schizophrenia.72 The definition of "caseness" - the point at which a patient can be regarded as suffering from psychosis and in need of treatment--would have to be adjusted, so that treatment for psychosis could be initiated even in the absence of a definitive diagnosis of schizophrenia. 50. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzen LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145-51. 51. Strauss JS, Carpenter AAT Jr. Prediction of outcome in schizophrenia: III. Five-year outcome and its predictors. Arch Gen Prychiatry 1977;34:159-63. 52. Kendler KS, Gruenberg .MU, Tsuang MT. Outcome of schizophrenic subtypes defined by four diagnostic systems. Arch Gen Psychiat 1984;41:149-54. 53. Peterson DB, Olson GW. First admitted schizophrenics in drug era. Arch Gen Psychiatry 1964;11:137-44.</abstract><cop>Canada</cop><pub>CMA Impact, Inc</pub><pmid>10189434</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0820-3946 |
ispartof | Canadian Medical Association journal (CMAJ), 1999-03, Vol.160 (6), p.843-846 |
issn | 0820-3946 1488-2329 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1230170 |
source | PubMed Central |
subjects | Antipsychotic Agents - therapeutic use Disease Progression Humans Mental disorders Nursing Predictive Value of Tests Prognosis Review Risk Factors Schizophrenia Schizophrenia - diagnosis Schizophrenia - drug therapy Therapy Time Factors Treatment Outcome |
title | Improving outcome in schizophrenia: the case for early intervention |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improving%20outcome%20in%20schizophrenia:%20the%20case%20for%20early%20intervention&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Malla,%20A%20K&rft.date=1999-03-23&rft.volume=160&rft.issue=6&rft.spage=843&rft.epage=846&rft.pages=843-846&rft.issn=0820-3946&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69668145%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p289t-62628d49446f3aec98a31219831acbbc091fe0aa7f139f60c4f5f42bfff4c7f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=204795570&rft_id=info:pmid/10189434&rfr_iscdi=true |